New COVID-19 vaccine shows promise in large trial
NCT ID NCT05212948
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study tested a new vaccine called S-268019 to see if it can prevent COVID-19. About 9,900 adults who had never had COVID-19 received either the vaccine or a placebo. Researchers tracked how many people got sick with COVID-19 at least 14 days after their second shot.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Buon Ma Thuot City Medical Center
Buon Ma Thuot, Dak Lak, Vietnam
Conditions
Explore the condition pages connected to this study.